Letters from FDA underscore heated rivalry

11/8/2012 | Pharmalot.com

The FDA Office of Prescription Drug Promotion issued in October untitled letters to Cornerstone Therapeutics and ONY Pharmaceuticals for promoting their respective drugs for neonatal respiratory disease syndrome. The two drugmakers are cited by the FDA for making unsupported superiority claims and omitting risk information. The letters are a sign of what can happen when drugs are marketed at the expense of rivals, according to this article.

View Full Article in:

Pharmalot.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN